STAMFORD, Conn.--(BUSINESS WIRE)--

Alliance for Cancer Gene Therapy, Inc. (ACGT), http://www.acgtfoundation.org, https://twitter.com/acgtfoundation, and https://www.facebook.com/acgtfoundation, today announced that it will be hosting an inaugural Foundation Symposium Gene and Cell Therapy For Cancer on Thursday, May 16, from 6:00 p.m. to 8:00 p.m., Ballroom B, at the 16th Annual American Society of Gene and Cell Therapy Meeting, May 15-18, Salt Palace Convention Center, in Salt Lake City, Utah. The Symposium will be co-chaired by Xandra O. Breakefield, PhD, Massachusetts General Hospital, and Savio L.C. Woo, PhD, Mount Sinai School of Medicine.

This ACGT-sponsored Symposium will present state-of-the-art lectures by leading investigators in four exceptionally promising areas of scientific research and translational development in gene and cell therapies for cancer. Over the past decade, the power of gene and cell therapies has been harnessed into novel bio-therapeutics for the treatment of many different cancers that are both effective and safe.

We are honored to partner with ASGCT and to feature some of the worlds most renowned scientists, physicians and researchers in the field of cell and gene therapy, said Barbara Netter, ACGT President and Co-Founder.

Speakers and Topics Include:

ACGT is the only not-for-profit in the U.S. dedicated solely to cancer cell and gene therapies for all types of cancer. 100% of contributions go directly to research. ACGT has funded 41 grants from public donations since its founding in 2001 totaling almost $25 million for both basic research and clinical translation. Seventeen ACGT funded research projects have been approved for human clinical trials, 11 of which are underway. To donate, please visit http://www.acgtfoundation.org or call 203.358.8000.

See original here:
Alliance for Cancer Gene Therapy to Host Inaugural Foundation Symposium at the 16th Annual American Society of Gene ...

Comments are closed.